- Home
- CREG vs RNAZ Comparison
CREG vs RNAZ Comparison
Compare CREG & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- RNAZ
- Stock Information
- Founded
- CREG N/A
- RNAZ 2016
- Country
- CREG China
- RNAZ United States
- Employees
- CREG N/A
- RNAZ N/A
- Industry
- CREG Power Generation
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- CREG Utilities
- RNAZ Health Care
- Exchange
- CREG Nasdaq
- RNAZ Nasdaq
- Market Cap
- CREG 5.9M
- RNAZ 6.1M
- IPO Year
- CREG N/A
- RNAZ 2021
- Fundamental
- Price
- CREG $0.23
- RNAZ $8.73
- Analyst Decision
- CREG
- RNAZ Strong Buy
- Analyst Count
- CREG 0
- RNAZ 1
- Target Price
- CREG N/A
- RNAZ $280.00
- AVG Volume (30 Days)
- CREG 4.9M
- RNAZ 24.7K
- Earning Date
- CREG 08-13-2025
- RNAZ 08-13-2025
- Dividend Yield
- CREG N/A
- RNAZ N/A
- EPS Growth
- CREG N/A
- RNAZ N/A
- EPS
- CREG N/A
- RNAZ N/A
- Revenue
- CREG $20,625.00
- RNAZ N/A
- Revenue This Year
- CREG N/A
- RNAZ N/A
- Revenue Next Year
- CREG N/A
- RNAZ N/A
- P/E Ratio
- CREG N/A
- RNAZ N/A
- Revenue Growth
- CREG N/A
- RNAZ N/A
- 52 Week Low
- CREG $0.20
- RNAZ $6.15
- 52 Week High
- CREG $1.47
- RNAZ $905.52
- Technical
- Relative Strength Index (RSI)
- CREG 32.10
- RNAZ 52.29
- Support Level
- CREG $0.22
- RNAZ $8.28
- Resistance Level
- CREG $0.26
- RNAZ $9.15
- Average True Range (ATR)
- CREG 0.02
- RNAZ 0.61
- MACD
- CREG 0.01
- RNAZ 0.23
- Stochastic Oscillator
- CREG 53.67
- RNAZ 57.63
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.